Janux Therapeutics JANX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Janux Therapeutics's total liabilities?
- Janux Therapeutics (JANX) reported total liabilities of $86.69M in Q1 2026.
- How has Janux Therapeutics's total liabilities changed year-over-year?
- Janux Therapeutics's total liabilities increased by 126.3% year-over-year, from $38.3M to $86.69M.
- What is the long-term trend for Janux Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), Janux Therapeutics's total liabilities has grown at a 37.1% compound annual growth rate (CAGR), from $9.23M to $44.74M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.